Abstract
The first generation of Nitric Oxide Synthases inhibitors was synthesized in the late 1980’s and early 1990’s; they were mainly amino acid derivatives, binding to the same residues within the enzyme heme-active site with respect to the natural substrate L-Arg, and showed no or scarce selectivity. In 1994, the N-(3-(aminomethyl)-benzyl) acetamidine (1400W), a highly selective compound for human iNOS versus both human eNOS and nNOS, was discovered. Following this landmark discover several other amidine-based iNOS and nNOS selective inhibitors have been disclosed. In this review we will focus on the recent progress and perspectives in the development of amidine-based selective iNOS and nNOS, including close analogues, with particular attention to acetamidine and aminopyridine derivatives.
Keywords: Acetamidine, amidine, 2-aminopyridine, nitric oxide synthases (NOS), NOS inhibitors.
Current Enzyme Inhibition
Title:Recent Developments of Amidine-like Compounds as Selective NOS Inhibitors
Volume: 12 Issue: 1
Author(s): Nazzareno Re, Marialuigia Fantacuzzi, Cristina Maccallini, Roberto Paciotti and Rosa Amoroso
Affiliation:
Keywords: Acetamidine, amidine, 2-aminopyridine, nitric oxide synthases (NOS), NOS inhibitors.
Abstract: The first generation of Nitric Oxide Synthases inhibitors was synthesized in the late 1980’s and early 1990’s; they were mainly amino acid derivatives, binding to the same residues within the enzyme heme-active site with respect to the natural substrate L-Arg, and showed no or scarce selectivity. In 1994, the N-(3-(aminomethyl)-benzyl) acetamidine (1400W), a highly selective compound for human iNOS versus both human eNOS and nNOS, was discovered. Following this landmark discover several other amidine-based iNOS and nNOS selective inhibitors have been disclosed. In this review we will focus on the recent progress and perspectives in the development of amidine-based selective iNOS and nNOS, including close analogues, with particular attention to acetamidine and aminopyridine derivatives.
Export Options
About this article
Cite this article as:
Re Nazzareno, Fantacuzzi Marialuigia, Maccallini Cristina, Paciotti Roberto and Amoroso Rosa, Recent Developments of Amidine-like Compounds as Selective NOS Inhibitors, Current Enzyme Inhibition 2016; 12 (1) . https://dx.doi.org/10.2174/1573408012999151109100557
DOI https://dx.doi.org/10.2174/1573408012999151109100557 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Probe Development of Technetium-99m Molecular Imaging Agents
Current Organic Synthesis Modulation of Ion Channels in Pulmonary Arterial Hypertension
Current Pharmaceutical Design Sustained Delivery of Interferons by Micro- and Nanosystems
Recent Patents on Materials Science Drug Metabolism and Transport Under Hypoxia
Current Drug Metabolism Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives
Anti-Cancer Agents in Medicinal Chemistry The Applications of Pharmacogenomics to Neurological Disorders
Current Molecular Medicine Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Vascular Reactions of Iodinated X-Ray Contrast Media: Mechanisms and Possible Therapeutic Interventions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense
Current Enzyme Inhibition Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs
Current Drug Metabolism 4’-Aminochalcones As Novel Inhibitors of the Chlorinating Activity of Myeloperoxidase
Current Medicinal Chemistry Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Vitamin C Inhibits Angiotensin-Converting Enzyme-2 in Isolated Rat Aortic Ring
Cardiovascular & Hematological Disorders-Drug Targets Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets Patent Selections
Recent Patents on Cardiovascular Drug Discovery Synthesis of Novel Benzothiazole-Piperazine Derivatives and Their Biological Evaluation as Acetylcholinesterase Inhibitors and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Mini-Reviews in Medicinal Chemistry Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors
Current Medicinal Chemistry